Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to evaluate the safety and efficacy of mesenchymal stem cells (MSCs) obtained from bone marrow for the treatment of adults with active proliferative lupus nephritis. The objective of this study is to evaluate the efficacy of mesenchymal stem cells (MSCs) in achieving a full or partial response in the treatment of Lupus Nephritis (LN) during its induction period.
Epistemonikos ID: 5dac326c98f7b28f93b4eea8bbe14f4bea9c44f7
First added on: May 21, 2024